Search results for:

baricitinib

baricitinib
Brand names: Olumiant
Form Strength
TABLET, ORAL 2 mg
Display Disease-Modifying Antirheumatic Drugs Class: 923600
Medication comments:
Per policy, these drugs are subject to renal dosing adjustments by pharmacy. 
Generic + Route
(Brand)
• Indications		 Usual Adult Dose
Comments		 Renal Dosage Adjustments
baricitinib PO
(Oluminant©)
• COVID-19 infection		 4 mg once daily eGFR ≥ 60: no adjustment necessary
eGFR 30 – 60: 2 mg once daily
eGFR 15 - 30: 1 mg once daily
eGFR < 15: use is not recommended
Last updated: Mar. 21, 2022
  • Renal Adjustment Policy baricitinib subject to adjustments by pharmacy.
Lexicomp Online Search

Pharmacy Contact Info:

Main Inpatient Pharmacy: ext 4599, 3503
Fax: 704-878-7283

Director of Pharmacy - Randi Raynor, PharmD: ext 4501
Clinical Coordinator - Laura Rollings, PharmD: ext 4597
Pharmacy Informaticist - Stephen Pringle, PharmD: ext 7645
Pharmacy Technician Supervisor - Amy Wingler, CPhT: ext 7385
Pharmacy Automation Coordinator (Omnicell) - Melissa Fulford, CPhT: ext 3556



This site is intended for the staff of Iredell Memorial Hospital.
While others may view accessible pages, Iredell Memorial Hospital makes no warranty, express or implied,
as to the use of this information outside of Iredell Memorial Hospital.
The content of this policy and procedure document serves as guidance to the delivery of quality patient care.
Care providers are expected to exercise critical thinking and situational awareness skills,
and in specific situations to take such action as is necessary for the delivery of quality patient care.
Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved